acetylcysteine has been researched along with Infarction, Middle Cerebral Artery in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (58.33) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, C; Denis, CV; Diamond, SL; Gakuba, C; Gauberti, M; Herbig, BA; Lenting, PJ; Martinez de Lizarrondo, S; Repessé, Y; Touzé, E; Vivien, D | 1 |
Budziszewska, B; Bystrowska, B; Filip, M; Krzyżanowska, W; Pera, J; Pomierny, B; Pomierny-Chamioło, L | 1 |
Liu, KJ; Shi, H; Taheri, S; Yan, J; Zhang, Z | 1 |
Budziszewska, B; Filip, M; Krzyzanowska, W; Pera, J; Pomierny, B | 1 |
Jin, X; Liu, CF; Liu, KJ; Liu, W; Liu, WC; Liu, Y; Pan, R; Shen, X; Shu, H; Sun, Y; Wang, X | 1 |
Igarashi, K; Ishii, I; Kashiwagi, K; Nishimura, K; Okuyama, S; Omura, T; Saiki, R | 1 |
Adams, J; Dave, JR; Elliott, PJ; Hale, SL; Moffett, JR; Tortella, FC; Williams, AJ | 1 |
Khan, M; Patel, SJ; Sekhon, B; Sekhon, C; Singh, AK; Singh, I | 1 |
Adams, J; Berti, R; Dave, JR; Elliott, PJ; Moffett, JR; Tortella, FC; Velarde, LC; Williams, AJ; Yao, C | 1 |
Adams, J; Berti, R; Dave, JR; Elliot, PJ; Tortella, FC; Williams, AJ | 1 |
Gilg, AG; Giri, S; Jatana, M; Khan, M; Sekhon, B; Sekhon, C; Singh, AK; Singh, I | 1 |
Adams, J; Elliott, PJ; Phillips, JB; Tortella, FC; Williams, AJ | 1 |
12 other study(ies) available for acetylcysteine and Infarction, Middle Cerebral Artery
Article | Year |
---|---|
Potent Thrombolytic Effect of
Topics: Acetylcysteine; Animals; Blood Platelets; Chlorides; Disease Models, Animal; Ferric Compounds; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Male; Mice; Platelet Aggregation; Ristocetin; Thromboembolism; Thrombosis; Tissue Plasminogen Activator; von Willebrand Factor | 2017 |
Ceftriaxone- and N-acetylcysteine-induced brain tolerance to ischemia: Influence on glutamate levels in focal cerebral ischemia.
Topics: Acetylcysteine; Amino Acid Transport Systems, Acidic; Animals; Astrocytes; Brain Ischemia; Ceftriaxone; Excitatory Amino Acid Transporter 2; Frontal Lobe; Gene Expression Regulation; Glutamic Acid; Hippocampus; Humans; Infarction, Middle Cerebral Artery; Rats; Synaptic Transmission | 2017 |
Hypoxia-inducible factor 1 contributes to N-acetylcysteine's protection in stroke.
Topics: Acetylcysteine; Animals; Brain Ischemia; Disease Models, Animal; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Rats; Reperfusion Injury; Signal Transduction; Stroke | 2014 |
N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression.
Topics: Acetylcysteine; Analysis of Variance; Animals; Brain; Brain Edema; Brain Infarction; Ceftriaxone; Disease Models, Animal; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Male; Nervous System Diseases; Neuroprotective Agents; Rats; Rats, Wistar; RNA, Messenger | 2016 |
Normobaric Hyperoxia Extends Neuro- and Vaso-Protection of N-Acetylcysteine in Transient Focal Ischemia.
Topics: Acetylcysteine; Animals; Blood-Brain Barrier; Brain Ischemia; Hyperoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Infarction, Middle Cerebral Artery; Male; Neuroprotection; Poly(ADP-ribose) Polymerases; Rats, Sprague-Dawley; Reperfusion Injury; Superoxides; Vascular Endothelial Growth Factor A | 2017 |
Intense correlation between brain infarction and protein-conjugated acrolein.
Topics: Acetylcysteine; Acrolein; Animals; Brain; Carrier Proteins; Disease Models, Animal; Down-Regulation; Free Radical Scavengers; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Photochemistry; Rose Bengal; Spermidine; Spermine; Time Factors; Up-Regulation | 2009 |
Delayed treatment with MLN519 reduces infarction and associated neurologic deficit caused by focal ischemic brain injury in rats via antiinflammatory mechanisms involving nuclear factor-kappaB activation, gliosis, and leukocyte infiltration.
Topics: Acetylcysteine; Animals; Astrocytes; Brain Ischemia; Cell Movement; Cysteine Endopeptidases; Gliosis; Infarction, Middle Cerebral Artery; Inflammation Mediators; Leukocytes; Male; Multienzyme Complexes; Nerve Degeneration; Nervous System Diseases; NF-kappa B; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Recovery of Function | 2003 |
N-Acetyl cysteine protects against injury in a rat model of focal cerebral ischemia.
Topics: Acetylcysteine; Animals; Brain; Free Radical Scavengers; Immunohistochemistry; Infarction, Middle Cerebral Artery; Male; Models, Theoretical; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2003 |
Effect of the proteasome inhibitor MLN519 on the expression of inflammatory molecules following middle cerebral artery occlusion and reperfusion in the rat.
Topics: Acetylcysteine; Animals; Cell Adhesion Molecules; Cysteine Endopeptidases; Cytokines; DNA; Gene Expression Regulation; Immunohistochemistry; Infarction, Middle Cerebral Artery; Inflammation; Kinetics; Male; Middle Cerebral Artery; Multienzyme Complexes; Neuroprotective Agents; NF-kappa B; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2003 |
Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519.
Topics: Acetylcysteine; Animals; Biomarkers; Brain Chemistry; Brain Ischemia; Chemotherapy, Adjuvant; Disease Models, Animal; E-Selectin; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Inflammation; Intercellular Adhesion Molecule-1; Male; Neuroprotective Agents; Neutrophil Infiltration; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2004 |
Administration of N-acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke.
Topics: Acetylcysteine; Animals; Brain Ischemia; Cerebrovascular Circulation; Cytokines; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Ectodysplasins; Free Radical Scavengers; Glial Fibrillary Acidic Protein; Glutathione; Immunohistochemistry; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Inflammation; Ischemic Attack, Transient; Male; Membrane Proteins; Neurologic Examination; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Time Factors | 2004 |
Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia.
Topics: Acetylcysteine; Animals; Cell Movement; Corpus Striatum; Cysteine Endopeptidases; Disease Models, Animal; Electroencephalography; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Macrophages; Male; Multienzyme Complexes; Neuroprotective Agents; Neutrophils; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Recovery of Function | 2000 |